Nail psoriasis;Łuszczyca paznokci

Przeglad Dermatologiczny

Volumn 97, Issue 4, 2010, Pages 243-252

  Wolska, Hanna ^a  

^a Klinika Dermatologiczna Medical University of Warsaw   (Poland)

Author keywords

Clinical features; Nail psoriasis; Systemic therapy; Topical therapy

Indexed keywords

ADALIMUMAB; CALCIPOTRIOL; CORTICOSTEROID; CYCLOSPORIN; INFLIXIMAB; PLACEBO; PSORALEN; RETINOID; TAZAROTENE; VITAMIN D DERIVATIVE;

DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERKERATOSIS; INTERPHALANGEAL JOINT; NAIL DISEASE; NAIL PSORIASIS; ONYCHOLYSIS; PSORIASIS; PUVA; QUALITY OF LIFE; REVIEW;

EID: 77957956990     PISSN: 00332526     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Jiaravuthisan M.M., Sasseville D., Vender R.B., Murphy F., Muhn C.Y.: Psoriasis of the nail: anathomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol 2007, 57, 1-27.
2. Reich K.: Approach to managing patients with nail psoriasis. JEADV 2009, 23 (supl. 1), 15-21.
3. Reich A.M., Blome C., Schafer I., Laass A., Radtke M.A.: Nail psoriasis in Germany: epidemiology and burden of the disease. Br J Dermatol 2010 (w druku).
4. Williamson L., Dalbeth N., Dockerty J.L.: Extended report: nail disease in psoriatic arthritis-clinically important, potentially treatable and often overlooked. Rheumatology 2004, 43, 790-794.
5. DeJong E.M.G.J., Seegers B.A.M.P.A., Gulinck M.K., Boezeman J.B.M., van de Kerkhof P.C.M.: Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1728 patients. Dermatology 1996, 193, 300-303.
6. Salomon J., Szepietowski J.C., Proniewicz A.: Psoriatic nail: a prospective clinical study. J Cutan Med Surg 2003, 7, 317-321.
7. Poindexter G.B., Scher R., Nendekar-Thomas M.A.: Psoriasis of the nails. [w:] Mild to moderate psoriasis. J.Y.M. Koo, C.S. Lee, M.G. Lebwohl (red.). Informa Healthcare, New York, London, 2009, 225-248.
8. Al-Mutairi N., Manchanda Y., Nour-Eldin O.: Nail changes in childhood psoriasis. A study from Kuwait. Pediatr Dermatol 2007, 24, 7-10.
9. Shemer A., Trau H., Davidovici B., Grunwald M.H., Amichai B.: Onychomycosis in psoriatic patients - rationalization of systemic treatment. Mycoses 2010, 53 (w druku).
10. Kacar N., Ergin S., Ergin C., Erdogan B.S., Kaleli I.: The prevalence, aetiological agents and therapy of onychomycosis in patients with psoriasis: a prospective controlled trial. Clin Exp Dermatol 2007, 32, 1-5.
11. Lavaroni G., Kokelj F., Pauluzzi P., Trevisan G.: The nail in psoriatic arthritis. Acta Derm Venereol Suppl (Stockh) 1994, 186, 113.
12. Love T., Gudjonsson J., Valdimarsson H., Gudbjornsson B.: Small joint involvement in psoriatic arthritis is associated with onycholysis: the Reykjavik Psoriatic Arthritis Study. Scand J Rheumatol 2010, 39, 299-302.
13. Taylor W., Gladman D., Helliwell P., Marchesoni A., Mease P., Mielants H.: Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006, 54, 2665-2673.
14. Duran-McKinster C., Ortiz-Solis D., Grandos J., Tamayo L., Orozco-Covarrubias L., Ruiz-Maldonaldo R.: Juvenile psoriatic arthritis with nail psoriasis in the absence of cutaneous lesions. Int J Dermatol 2000, 39, 32-35.
15. Tan A.L., Benjamin M., Toumi H., Grainger A.J., Tanner S.F., Emery P. i inni: The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis - a high-resolution MRI and histological study. Rheumatology 2007, 46, 253-256.
16. McGonagle D., McDermott M.F.: A proposed classification of the immunological diseases. PloS Med 2006, 3, 1242-1248.
17. McGonagle D., Tan A.L., Benjamin M.: The nail as a musculoskeletal appendage - implications for an improved understanding of the link between psoriasis and arthritis. Dermatology 2009, 218, 97-102.
18. Wilson F.C., Icen M., Crowson C.S., McEvoy M.T., Gabriel S.E., Kremers H.M.: Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population based study. Arthritis Rheumat 2009, 61, 233-239.
19. Rich P., Scher R.K.: Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol 2003, 49, 206-212.
20. Baran R.L.: A nail psoriasis severity index. Br J Dermatol 2004, 150, 568-569.
21. Marx J.L., Scher R.K.: Response of psoriatic nails to oral photochemotherapy. Arch Dermatol 1980, 116, 1023-1024.
22. Mahrle G., Schulze H.J., Farber L., Weidinger G., Steigleder G.K.: Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, joint involvement. J Am Acad Dermatol 1995, 32, 78-88.
23. Feliciani C., Zampetti A., Forleo P., Cerritelli L., Amerio P., Proietto G. i inni: Nail psoriasis: a combined therapy with systemic cyclosporin and topical calcipotriol. J Cutan Med 2004, 8, 122-125.
24. Rabinovitz H.S., Scher R.K., Shupack J.L.: Response of psoriatic nails to the aromatic retinoid etretinate. Arch Dermatol 1983, 119, 627-628.
25. Brazzelli V., Martinoli S., Prestinari F., Borroni G.: An impressive therapeutic result of nail psoriasis to acitretin. JEADV 2004, 18, 229-230.
26. Tosti A., Ricotti C., Romanelli P., Cameli N., Piraccini B.M.: Evaluation of the efficacy of acitretin therapy for nail psoriasis. Arch Dermatol 2009, 145, 269-271.
27. Baran R.: Retinoids and the nails. J Dermatol Treat 1990, 1, 151-154.
28. Cassetty C.T., Alexis A.F., Schupack J.L., Strober B.E.: Alefacept in the treatment of psoriatic nail disease: a small case series. J Am Acad Dermatol 2005, 52, 1101-1102.
29. Rallis E., Stavropoulou E., Rigopoulos D., Verros C.: Rapid response of nail psoriasis to etanercept. J Rheumatol 2008, 35, 544-545.
30. Bianchi L., Bergamin A., de Felice C., Capriotti E., Chimenti S.: Remission and time of resolution of nail psoriasis during infliximab therapy. J Am Acad Dermatol 2005, 52, 736-737.
31. Rigopoulos D., Gregoriou S., Stratigos A., Larios G., Krofitis C., Papaioannou D. i inni: Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study. Br J Dermatol 2008, 159, 453-456.
32. Rich P., Griffiths E.M., Reich K., Nestle F.O., Scher R.K., Li S. i inni: Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year. J Am Acad Dermatol 2008, 58, 224-231.
33. Noiles K., Vender R.: Nail psoriais and biologics. J Cutan Med Surg 2009, 13, 1-5.
34. Van den Bosch F., Manger B., Goupille P., McHugh N., Rodevand E., Holck P. i inni: Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions. Ann Rheum Dis 2010, 69, 394-399.
35. Rigopoulos D., Gregoriou S., Lazaridou E., Belyayeva E., Apalla Z., Makris M. i inni: Treatment of nail psoriasis with adalimumab: an open label unblended study. JEADV 2010, 24, 530-534.
36. Yamamoto T., Katayama I., Nishioka K.: Topical anthralin therapy for refractory nail psoriasis. J Dermatol 1998, 25, 231-233.
37. De Berker D.A.R., Lawrence C.M.: A simplified protocol of steroid injection for psoriatic nail dystrophy. Br J Dermatol 1998, 138, 90-95.
38. Wolf R., Tur E., Brenner S.: Corticosteroid induced "disappearing digiti". Arch Dermatol 1990, 126, 300-303.
39. Requena L., Zamora E., Martin L.: Acroatrophy secondary to long-standing applications of topical steroids. Arch Dermatol 1990, 126, 1013-1014.
40. Tosti A., Piraccini B.M., Cameli N., Kokely F., Plozzer C., Cannata G.E. i inni: Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethason dipropionate and salicylic acid. Br J Dermatol 1998, 139, 655-659.
41. Zakeri M., Valikhani M., Mortazavi H., Berzegari M.: Topical calcipotriol therapy in nail psoriasis: a study of 24 cases. Dermatol Online J 2005, 11, 1-5.
42. Rigopoulos D., Ioannides D., Prastitis N., Katsambas A.: Nail psoriasis: a combined treatment using calcipotriol cream and clobetasol propionate cream. Acta Derm Venereol 2002, 82, 140.
43. Marquez Balbas G., Sanchez Regana M., Umbert Millet P.: Tacalcitol ointment for the treatment of nail psoriasis. J Dermatolog Treat 2009, 20, 308-310.
44. Scher R.K., Stiller M., Zhu Y.I.: Tazarotene 0,1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study. Cutis 2001, 68, 355-358.
45. Bianchi L., Soda R., Diluvio L., Chimenti S.: Tazarotene 0,1% gel for psoriasis of the fingernails and toenails: an open, prospective study. Br J Dermatol 2003, 149, 207-209.
46. Rigopoulos D., Gregoriou S., Katsambas A.: Treatment of psoriatic nails with tazarotene cream 0,1% vs clobetasol propionate 0,05% cream: a double-blind study. Acta Derm Venereol 2007, 87, 167-189.
47. Fritz K.: Psoriasis of the nail: successful topical treatment with 5-fluorouracil. Z Hautkr 1989, 64, 1083-1088.
48. Schissel D.J., Elston D.M.: Topical 5-fluorouracil treatment for psoriatic trachyonychia. Cutis 1998, 62, 27-28.
49. De Jong E.M.G.J., Menke H.E., van Praag M.C.G., van der Kerkhof P.C.M.: Dystrophic psoriatic fingernails treated with 1% 5-fluorouracil in a nail penetration-enhancing vehicle: a double-blind study. Dermatology 1999, 199, 313-318.
50. Ortonne J.P.: 2010 (dane niepublikowane).
51. Baran and Dawber's diseases of the nails and their management (3 wyd.). R. Baran, R.P.R. Dawber, D.A.R. de Berker, E. Haneke, A.Tosti (red.) Blackwel Science Ltd, Oxford, 2001.